Immediate Impact
1 from Science/Nature 80 standout
Citing Papers
Osteoporosis
2024 Standout
Management of Menopausal Symptoms
2023 Standout
Works of Tetsuo Nakano being referenced
Clinical Efficacy on Fracture Risk and Safety of 0.5 mg or 1 mg/month Intravenous Ibandronate Versus 2.5 mg/day Oral Risedronate in Patients with Primary Osteoporosis
2013
Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Tetsuo Nakano | 653 | 472 | 374 | 37 | 1.0k | |
| Kichizo Yamamoto | 587 | 528 | 287 | 52 | 1.1k | |
| R. Pérez Cano | 1007 | 690 | 246 | 30 | 1.4k | |
| Albrecht W. Popp | 536 | 282 | 297 | 32 | 862 | |
| Julie T. Lin | 544 | 656 | 172 | 28 | 1.1k | |
| F. Caulin | 740 | 465 | 194 | 31 | 1.1k | |
| G Mazzuoli | 615 | 265 | 257 | 30 | 945 | |
| A. Bagur | 683 | 272 | 311 | 34 | 1.0k | |
| Se Hwa Kim | 296 | 209 | 168 | 49 | 870 | |
| Naomi Masunari | 440 | 245 | 163 | 19 | 1.0k | |
| R. L. Prince | 514 | 280 | 174 | 29 | 973 |
All Works
Loading papers...